NJ S257 | 2022-2023 | Regular Session

Note: Carry Foward to future S1488
Note: Carry Over of previous S873
Note: Carry Over of previous A735
Note: Carry Over of previous S3928
Note: Carry Over of previous A5551

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Establishes "Opioid Prevention and Rehabilitation Program Fund" and tax on opioid drugs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishes "Opioid Prevention and Rehabilitation Program Fund" and tax on opioid drugs.

Sponsors


History

DateChamberAction
2022-01-11SenateIntroduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Same As/Similar To

S257 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S873 (Carry Over) 2020-01-27 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A735 (Carry Over) 2020-01-14 - Introduced, Referred to Assembly Health Committee
S3928 (Carry Over) 2021-06-24 - Withdrawn from Consideration
A5551 (Carry Over) 2021-05-05 - Introduced, Referred to Assembly Environment and Solid Waste Committee

Subjects


New Jersey State Sources


Bill Comments

feedback